Societe Commerciale Euro-Taiwanaise
✅ Low Risk
FEI: 3004142507 • Taipei, FN • TAIWAN
FEI Number
3004142507
Location
Taipei, FN
Country
TAIWANAddress
No.112, Sec.2, 3 Fl.; Chung Shan N. Road, Taipei, FN, Taiwan
Low Risk
FDA Import Risk Assessment
This firm has a minimal history of FDA import refusals with low-severity violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
REGISTERED
It appears the device is subject to listing under 510(j) and the initial distributor has not registered as required by 21 CFR 807.20 (a)(5).
Refusal History
Frequently Asked Questions
What is Societe Commerciale Euro-Taiwanaise's FDA import refusal history?
Societe Commerciale Euro-Taiwanaise (FEI: 3004142507) has 2 FDA import refusal record(s) in our database, spanning from 6/8/2004 to 6/8/2004.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Societe Commerciale Euro-Taiwanaise's FEI number is 3004142507.
What types of violations has Societe Commerciale Euro-Taiwanaise received?
Societe Commerciale Euro-Taiwanaise has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Societe Commerciale Euro-Taiwanaise come from?
All FDA import refusal data for Societe Commerciale Euro-Taiwanaise is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.